AXELIOS

Serial Number 99177562
686

Registration Progress

Application Filed
May 9, 2025
Under Examination
Approved for Publication
Nov 11, 2025
Published for Opposition
Nov 11, 2025
Registered

Trademark Image

AXELIOS

Basic Information

Serial Number
99177562
Filing Date
May 9, 2025
Published for Opposition
November 11, 2025
Drawing Code
5

Status Summary

Current Status
Active
Status Code
686
Status Date
Nov 11, 2025
Application
Pending
Classes
005 010

Rights Holder

Roche Molecular Systems, Inc.

03
Address
4300 Hacienda Drive
Pleasanton, CA 94588

Ownership History

Roche Molecular Systems, Inc.

Original Applicant
03
Pleasanton, CA

Roche Molecular Systems, Inc.

Owner at Publication
03
Pleasanton, CA

Legal Representation

Attorney
Mona Gupta

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Nov 11, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 11, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 5, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 13, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 8, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 7, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 7, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 30, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 30, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 24, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 19, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 9, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 9, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for genetic testing; chemical reagents, preparations and test kits for nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with dna sequencing and genetic analysis
Class 010
Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers, imaging devices and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit; medical equipment, namely, devices for analyzing nucleic acids and for dna sequencing for the purpose of rendering medical treatment and diagnosis, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit

Additional Information

Design Mark
The mark consists of the stylized wording AXELIOS in uppercase, thick black lettering. The letter X is formed by two symmetrical, curved lines crossing in the center, where the lines to the right curve out horizontally. The E is formed by three horizontal lines without a vertical spine, connected at the top and bottom to the letter X, creating a visual link between the two characters. The middle line in the E is aligned evenly between the top and bottom lines. The remaining letters, A, L, I, O, and S, are presented in a uniform, uppercase font.

Classification

International Classes
005 010